3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
8
Carcinoma
5
Squamous Cell Carcinoma of Head and Neck
3
Recurrence
3
Mouth Neoplasms
3
Colorectal Neoplasms
3
Adenocarcinoma
3
Skin Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Mycosis Fungoides
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, T-Cell
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell
2
Laryngeal Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Breast Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sinonasal Squamous Cell Carcinoma
1
Sarcoma
1
Resectable Non-small Cell Lung Cancer
1
Rectal Neoplasms
1
Interventions
Gemcitabine
8
Cisplatin
8
durvalumab
4
Oxaliplatin
3
Irinotecan
3
Folfox protocol
3
Bevacizumab
3
zanidatamab
2
pembrolizumab
2
Fluorouracil
2
Capecitabine
2
tremelimumab
1
trastuzumab deruxtecan
1
toripalimab
1
poly ICLC
1
niraparib
1
neratinib
1
ivosidenib
1
futibatinib
1
fludarabine
1
envafolimab
1
encorafenib
1
brigimadlin
1
binimetinib
1
apatinib
1
Trastuzumab
1
Self Expandable Metallic Stents
1
Psilocybin
1
Peptides
1
Pemetrexed
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Biliary Tract Neoplasms
×
cemiplimab
×
30 days
×
Clear all
No trials found.